Citibank (C) Stock
NYSE · C
Fundamentals
Market cap
$215.55B
Price / Earnings ratio
11.9x
Price / Sales ratio
2.3x
Price / Book ratio
1.0x
Return on assets
1.0%
Ex-Dividend date
3 Aug 2026
Last payment date
28 Aug 2026
Dividend amount
$0.60
Dividend yield
1.92%
Recent news
Stocktwits
Jim Cramer Warns Q3 ‘Earnings Deluge’ May Not Be As Strong As Previous Quarter — ‘Much More Difficult Backdrop’
NeutralCOctober 3, 2026
StocktwitsNeutral
Jim Cramer Warns Q3 ‘Earnings Deluge’ May Not Be As Strong As Previous Quarter — ‘Much More Difficult Backdrop’
C
Zacks Investment Research
Jobs Market Stays Flat at +29K, Futures Love It
NeutralCOctober 2, 2026
Zacks Investment ResearchNeutral
Jobs Market Stays Flat at +29K, Futures Love It
C
CNBC
'The hottest skill on Wall Street': Demand for this AI ability jumped 1,721% as banks embrace agents
NeutralCOctober 2, 2026
CNBCNeutral
'The hottest skill on Wall Street': Demand for this AI ability jumped 1,721% as banks embrace agents
C
CNBC
How AI is redefining Wall Street jobs — and boosting demand for this new 'hottest skill' by 1,721%
NeutralCOctober 2, 2026
CNBCNeutral
How AI is redefining Wall Street jobs — and boosting demand for this new 'hottest skill' by 1,721%
CTechnical indicators
- RSI 14
- 39.30
- MACD 12/26/9
- -1.57
- EMA 9 of MACD
- -0.89
- MACD histogram
- -0.68
- SMA 50
- $133.93
- Price below SMA 50
- EMA 50
- $133.44
- Price below EMA 50
- SMA 200
- $125.87
- Price above SMA 200
- EMA 200
- $124.07
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of October 2, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 7 analysts
Strong Sell0
Sell0
Hold2
Buy5
Strong Buy0
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Revenue
Net income
Net margin %
2021
2022
2023
2024
2025
102B67B34B0
Debt & Balance Sheet
Total assets
Total liabilities
2021
2022
2023
2024
2025
3T2T1T0
Revenue to Profit
2025$85.2B
Revenue$0.0
Cost of revenue$0.0
Gross profit$0.0
Operating expenses$14.3B
Net incomeEarnings
EPS forecast
Actual EPS
$2.24
$1.78
Q3FY25
$1.80
Q4FY25
$2.47
Q1FY26
$2.49
Q2FY26
$2.55
Q3FY26
The market is expecting earnings per share of $2.55 for this quarter. The company has not yet shared when it is announcing earnings.
% positive news of 10 articles
in the news listed below
Latest news
Stocktwits
Jim Cramer Warns Q3 ‘Earnings Deluge’ May Not Be As Strong As Previous Quarter — ‘Much More Difficult Backdrop’
NeutralCOctober 3, 2026
StocktwitsNeutral
Jim Cramer Warns Q3 ‘Earnings Deluge’ May Not Be As Strong As Previous Quarter — ‘Much More Difficult Backdrop’
CZacks Investment Research
Jobs Market Stays Flat at +29K, Futures Love It
NeutralCOctober 2, 2026
Zacks Investment ResearchNeutral
Jobs Market Stays Flat at +29K, Futures Love It
CCNBC
'The hottest skill on Wall Street': Demand for this AI ability jumped 1,721% as banks embrace agents
NeutralCOctober 2, 2026
CNBCNeutral
'The hottest skill on Wall Street': Demand for this AI ability jumped 1,721% as banks embrace agents
CCNBC
How AI is redefining Wall Street jobs — and boosting demand for this new 'hottest skill' by 1,721%
NeutralCOctober 2, 2026
CNBCNeutral
How AI is redefining Wall Street jobs — and boosting demand for this new 'hottest skill' by 1,721%
C
Zacks Investment Research
Citigroup (C) Stock Declines While Market Improves: Some Information for Investors
NeutralCOctober 1, 2026
Zacks Investment ResearchNeutral
Citigroup (C) Stock Declines While Market Improves: Some Information for Investors
C
24/7 Wall Street
Bank Stocks Slide as Money-Center Names Lead Financials Lower: Citigroup Falls 4%, Bank of America Drops 3%, JPMorgan Chase Slips
NeutralCOctober 1, 2026
24/7 Wall StreetNeutral
Bank Stocks Slide as Money-Center Names Lead Financials Lower: Citigroup Falls 4%, Bank of America Drops 3%, JPMorgan Chase Slips
C
24/7 Wall Street
Moderna Climbs 3% Despite Citigroup's Downgrade to Sell; BioNTech Inches Higher, Pfizer Treads Water
NeutralCOctober 1, 2026
24/7 Wall StreetNeutral
Moderna Climbs 3% Despite Citigroup's Downgrade to Sell; BioNTech Inches Higher, Pfizer Treads Water
C
Zacks Investment Research
Fed Revamps Bank Stress Tests: What Does it Mean for U.S. Banks?
NeutralCOctober 1, 2026
Zacks Investment ResearchNeutral
Fed Revamps Bank Stress Tests: What Does it Mean for U.S. Banks?
C
Stocktwits
IBRX Stock Racks Up 3 Straight Quarterly Wins: Q3 Filings Reveal BlackRock Closing In On Vanguard With A Bigger Bet
NeutralCOctober 1, 2026
StocktwitsNeutral
IBRX Stock Racks Up 3 Straight Quarterly Wins: Q3 Filings Reveal BlackRock Closing In On Vanguard With A Bigger Bet
C
Reuters
Fed finalizes bank 'stress test' overhaul
NeutralCSeptember 30, 2026
ReutersNeutral
Fed finalizes bank 'stress test' overhaul
CAbout Citibank
While we're a global bank, our mission is simple: We responsibly provide financial services that enable growth and economic progress Citi works tirelessly to provide consumers, corporations, governments and institutions with a broad range of financial services and products. We strive to create the best outcomes for our clients and customers with financial ingenuity that leads to solutions that are simple, creative and responsible.
SectorFinancial Services
IndustryBanks - Diversified
Employees219,000
CEOMs. Jane Nind Fraser Ph.D.
IPO DateJan 3, 1977
HeadquartersNew York, NY
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Ms. Jane Nind Fraser Ph.D. | CEO & Chair of the Board | 1968 |
| Mr. Mark A.L. Mason | Executive Vice Chairman and Senior Executive Advisor to Chair & CEO | 1970 |
| Engineer Ernesto Torres Cantu | Head of International | 1964 |
| Mr. Andrew J. Morton | Head of Markets | 1962 |
| Mr. Viswas Raghavan | Executive Vice Chairman & Head of Banking | 1966 |
| Mr. Gonzalo Luchetti | Chief Financial Officer | 1974 |
| Mr. Anand Selvakesari | Chief Operating Officer | 1968 |
| Ms. Nicole Giles | Chief Accounting Officer & Controller | 1972 |
| Mr. Achintya Mangla | Head of Investment Banking Financing | — |
| Ms. Jennifer Landis | Head of Investor Relations | — |
Fundamentals
Valuation
Market cap$215.55B
Price-to-sales ratio2.33
Price-to-book value1.00
Price-earnings ratio11.90
Return on Equity8.00%
Return on Sales27.00%
Return on Assets1.00%
PEG ratio0.60
Earnings Per Share
Earnings Per Share$9.45
Income Statement
Average volume9,925,061
EBITDA$28.76B
1 year high (52w)$147.96
1 year low (52w)$93.66
Dividend
Ex dividend date3 Aug 2026
Dividend amount$0.60
Dividend yield1.92%
Last payment date28 Aug 2026
Next earnings report13 Oct 2026
Technical indicators
- RSI 14
- 39.30
- MACD 12/26/9
- -1.57
- EMA 9 of MACD
- -0.89
- MACD histogram
- -0.68
- SMA 50
- $133.93
- Price below SMA 50
- EMA 50
- $133.44
- Price below EMA 50
- SMA 200
- $125.87
- Price above SMA 200
- EMA 200
- $124.07
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of October 2, 2026. Technical data, not a recommendation.
Analyst views
7 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Analyst consensus:Buy
71% Buy
29% Hold
0% Sell
Analyst price target
- Low
- $140.00
- Average
- $153.29
- High
- $176.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -4.5 | -8.5 | -3.4 | |||||||||
| 2022 | +3.2 | -11.0 | -8.9 | -7.9 | +9.6 | -12.2 | +10.7 | -6.0 | -14.5 | +7.8 | +4.7 | -5.3 |
| 2023 | +14.1 | -2.8 | -9.0 | +0.8 | -6.2 | +2.7 | +2.0 | -12.3 | -1.1 | -2.5 | +16.4 | +8.9 |
| 2024 | +5.9 | -1.0 | +13.7 | -3.4 | +1.6 | +2.5 | +2.3 | -1.0 | +1.9 | +3.8 | +11.2 | -1.4 |
| 2025 | +16.4 | +0.4 | -8.0 | -3.1 | +10.5 | +12.3 | +8.6 | +5.2 | +7.1 | +2.6 | +2.0 | +13.6 |
| 2026 | -2.5 | -5.2 | +1.8 | +11.0 | -1.2 | +8.4 | -5.5 | -1.5 | -2.3 | +1.2 |
Corporate actions
Upcoming
No upcoming corporate actions for C
Past
DividendQ3/26
Ex-dividend date3 Aug 2026
Payable date28 Aug 2026
Amount per share$0.67
DividendQ2/26
Ex-dividend date4 May 2026
Payable date22 May 2026
Amount per share$0.60
DividendQ1/26
Ex-dividend date2 Feb 2026
Payable date27 Feb 2026
Amount per share$0.60
DividendQ4/25
Ex-dividend date3 Nov 2025
Payable date26 Nov 2025
Amount per share$0.60
DividendQ3/25
Ex-dividend date4 Aug 2025
Payable date22 Aug 2025
Amount per share$0.60
DividendQ2/25
Ex-dividend date5 May 2025
Payable date23 May 2025
Amount per share$0.56
DividendQ1/25
Ex-dividend date3 Feb 2025
Payable date28 Feb 2025
Amount per share$0.56
DividendQ4/24
Ex-dividend date4 Nov 2024
Payable date22 Nov 2024
Amount per share$0.56
DividendQ3/24
Ex-dividend date5 Aug 2024
Payable date23 Aug 2024
Amount per share$0.56
DividendQ2/24
Ex-dividend date3 May 2024
Payable date24 May 2024
Amount per share$0.53
DividendQ1/24
Ex-dividend date2 Feb 2024
Payable date23 Feb 2024
Amount per share$0.53
DividendQ4/23
Ex-dividend date3 Nov 2023
Payable date22 Nov 2023
Amount per share$0.53
DividendQ3/23
Ex-dividend date4 Aug 2023
Payable date25 Aug 2023
Amount per share$0.53
DividendQ2/23
Ex-dividend date28 Apr 2023
Payable date26 May 2023
Amount per share$0.51
DividendQ1/23
Ex-dividend date3 Feb 2023
Payable date24 Feb 2023
Amount per share$0.51
DividendQ4/22
Ex-dividend date4 Nov 2022
Payable date23 Nov 2022
Amount per share$0.51
DividendQ3/22
Ex-dividend date29 Jul 2022
Payable date26 Aug 2022
Amount per share$0.51
DividendQ2/22
Ex-dividend date29 Apr 2022
Payable date27 May 2022
Amount per share$0.51
DividendQ1/22
Ex-dividend date4 Feb 2022
Payable date25 Feb 2022
Amount per share$0.51
DividendQ4/21
Ex-dividend date29 Oct 2021
Payable date24 Nov 2021
Amount per share$0.51
